1. Introduction {#sec1-1}
===============

Studying microcirculation in the retina plays an important role in ophthalmic research. Because the retina is a highly energy-demanding tissue, an abnormal oxygen supply may lead to several vision disorders. For example, retinal degeneration \[[@r1]\], diabetic retinopathy \[[@r2]\] and retinopathy of prematurity \[[@r3]\] have been reported to be correlated with disrupted local retinal oxygen environments, which can be quantified by intraretinal oxygen distribution and metabolic rate of oxygen (MRO~2~, also can be referred to oxygen consumption). Hence, a technology that is able to measure MRO~2~ in the retina is desired. Such a technology should possess the following characteristics: (1) noninvasiveness; (2) label-free; (3) fast-acquisition; (4) high-spatial resolution, and (5) capable of measuring multiple functional parameters, such as hemoglobin oxygen saturation (sO~2~) and blood flow; however, no existing technology satisfies all the above requirements.

Currently, measuring retinal MRO~2~ primarily relies on oxygen-sensitive microelectrodes \[[@r1],[@r2]\], which is not only invasive but also terminal. Blood-oxygen-level-dependent contrast MRI has also been used to measure ocular MRO~2~; however, its spatial resolution is insufficient in microcirculation studies \[[@r4],[@r5]\]. Fundus photography-based retinal oximetry has the potential to quantify sO~2~ \[[@r6],[@r7]\] and several optical coherence tomography (OCT) based technologies have been reported to measure retinal blood flow \[[@r8]--[@r12]\]; but each individual technology is insufficient to measure MRO~2~ as both sO~2~ and blood flow measurements are required.

Here, we demonstrate the feasibility of measuring MRO~2~ at the microvascular level *in vivo* without extrinsic contrast agent using a combined laser-scanning optical-resolution photoacoustic microscopy (LSOR-PAM) and spectral-domain OCT (SD-OCT).

2. Methods and materials {#sec1-2}
========================

To measure the MRO~2~ *in vivo*, we selected an artery-vein pair and acquired the following parameters: the sO~2~ in artery and vein (sO~2a~ and sO~2v~, dimensionless), the mean total hemoglobin concentration ($\overline{\text{HbT}}$, g/L) in blood, the diameters of the artery and vein (*d~a~* and *d~v~*, m), and the mean blood flow velocities in the artery and vein (${\overline{v}}_{a}$ and${\overline{v}}_{v}$, m/s). Assuming that vessels have circular cross-sections, total hemoglobin concentration is constant, and each hemoglobin molecule carries four oxygen molecules, the MRO~2~ (g/min) is given by
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where W~O2~ and W~HbO2~ are the molecular weights of O~2~ and oxy-hemoglobin, which are 32 and 68000, respectively.

In [Eq. (1)](#e1){ref-type="disp-formula"}, the sO~2~ was calculated based on multi-wavelength LSOR-PAM measurements \[[@r13]--[@r15]\]. The $\overline{\text{HbT}}$ was measured from blood samples by a commercial veterinary laboratory. The diameters of the blood vessels were measured by LSOR-PAM along the lateral direction.

The mean blood flow velocity was measured by the SD-OCT based on \[[@r8]\]
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where *f*~sample~ is the A-line rate; *λ*~0~ is the central wavelength of the probing light; *n* is the refractive index of sample (\~1.4 for soft tissue and \~1.33 for water); *∆φ* is the unwrapped phase shift between adjacent A-lines which ranged in \[-π, + π\]; and *θ* is the OCT Doppler angle (the angle between incident probing light and the blood vessel flow direction).

The schematic of the integrated LSOR-PAM and SD-OCT is shown in [Fig. 1](#g001){ref-type="fig"} Fig. 1Schematics of the combined LSOR-PAM and SD-OCT. PD: photodiode; 2 × 2: 2 × 2 single-mode optical fiber coupler; HM: hot mirror; GM: 2D galvanometer; OBJ: objective lens; AMP: amplifier; UT: ultrasonic transducer; WT: water tank; SLED: superluminescent emitting diode; Ref: OCT reference arm.. The optical illumination and ultrasonic detection in the LSOR-PAM have been described elsewhere \[[@r16],[@r17]\]. To brief, we used a tunable dye laser (Cobra, Sirah Laser and Plasmatchnik GmbH) pumped by a Nd:YLF laser (IS8II-E, Edge-Wave GmbH; pulse duration: 6 ns; repetition rate: 1024 Hz) as the irradiation source. The dye laser output was coupled into a single mode optical fiber and was then merged with the OCT probing light by a dichroic mirror (NT43-955, Edmund Optics). The combined beams were scanned by an x--y galvanometer (6230H, Cambridge Technology) and were focused by an achromatic lens with 40-mm focal length (AC254-040-A1, Thorlabs). We used four optical wavelengths (570 nm, 578 nm, 588 nm, and 590 nm) in the multiwavelength measurement for sO~2~.

A custom-built unfocused needle ultrasonic transducer (center frequency: 35 MHz; bandwidth: 50%; active element size: 0.5 × 0.5 mm^2^) was used to detect the PA waves. The detected PA signals were amplified by 49 dB and were digitized by a high speed digitizer (CS 14200, Gage Applied) at a sampling rate of 200 MS/s. The energy of each laser pulse was sampled by the photodiode PD2 (DET10A, Thorlabs) to compensate for the pulse energy instability. As reported in our previous work, the lateral resolution of the LSOR-PAM is 2.8 µm, and the axial resolution is 23 µm \[[@r18]\].

The SD-OCT system used a broadband superluminescent emitting diode (SLED) as the light source (IPSDD0804, InPhenix; center wavelength λ~0~: 840 nm; 3-dB bandwidth ∆λ: 50 nm). The output light was coupled into a 2 × 2 single-mode optical ﬁber coupler after being attenuated by 3 dB. A home-made spectrometer was used to detect the interference light with an A-line rate (*f*~sample~) of 24 kHz. The axial resolution is 6 µm in tissue and the lateral resolution is 20 µm \[[@r17]\]. In order to measure flow, the animal holder and the water tank were both tilted by an angle (quantified in the acquired 3D OCT images) as shown in [Fig. 1](#g001){ref-type="fig"}.

A flow phantom was made of two polystyrene capillary tubes (CTPS125-250-5 and CTPS250-500-5, Paradigmoptics; inner diameters: 125 *µ*m and 250 *µ*m; outer diameters: 250 *µ*m and 500 *µ*m). The two tubes were glued interconnected and the thinner tube was connected to a perfusion pump (A-99, Razel) for flow control. As a result, the two tubes have identical flow rate but different flow velocity. Diluted red ink (10%) mixed with 1% Intralipid solution was used to mimic blood. The two tubes were placed in parallel at the bottom of the water tank and were tilted by 5.6° with respect to the OCT probing light.

In the *in vivo* experiment, a Swiss Webster mouse (Harlan Co.; body weight: 20 g) ear was imaged. The animal was anesthetized by a mixture of 1.5% isoﬂurane and regular air. After hairs were removed by a commercial nonirritating hair-removing lotion, the animal was fixed on a homemade animal holder during the imaging period. The mouse ear was placed on a flat supporter and the supporter was tilted by 3.8° with respect to the OCT probing light. The mouse was sacrificed after data acquisition and blood samples were taken for $\overline{\text{HbT}}$ measurement. All experimental animal procedures conformed to the laboratory animal protocol approved by the Animal Care and Use Committee of the University of Wisconsin--Milwaukee, where the experiments were conducted.

3. Results and discussions {#sec1-3}
==========================

3.1. Flow phantom results {#sec2-1}
-------------------------

[Figure 2](#g002){ref-type="fig"} Fig. 2Flow phantom imaging results. (a) LSOR-PAM image of the tubes (mean intensity projection); (b) PA amplitude profile along the dashed line in panel a; (c) flow velocity measured by Doppler OCT at the cross section marked in panel a; (d) the flow velocity profile at locations marked by the two dash lines in panel c. Bar: 250 *µ*m. shows the phantom imaging results. [Figure 2a](#g002){ref-type="fig"} is the LSOR-PAM mean-amplitude-projection image of the capillary tubes acquired at the optical wavelength of 570 nm. The angles between the center lines of the tubes with respect to the vertical axis of the image are measured to be 4.8° (left) and 2.4° (right), which were used to correct the measured tube diameters. [Figure 2b](#g002){ref-type="fig"} shows the PA amplitude (averaged for 32 times) along the dashed line in [Fig. 2a](#g002){ref-type="fig"} and the tube diameter were measured to be *d*~1~ = 134.46 ± 0.98 *µ*m (left) and *d*~2~ = 249.83 ± 0.39 *µ*m (right). [Figure 2c](#g002){ref-type="fig"} shows the Doppler OCT result measured at the location marked in [Fig. 2a](#g002){ref-type="fig"}. The Doppler angle was 84.4° and the calculated mean flow velocities were ${\overline{v}}_{1}$ = −11.20 ± 0.32 mm/s and ${\overline{v}}_{2}$ = 3.40 ± 0.37 mm/s. The sign of the velocity represents the flow direction.

We compared the flow rates $F = {{60 \cdot \pi \cdot d^{2} \cdot \left| \overline{v} \right|}/4}$ between the two capillary tubes. The pump was set at flow rate of 0.595 cc/hr (9.92 *µ*l/min); and we calculated that *F*~1~ = 9.51 ± 0.14 *µ*l/min and *F*~2~ = 9.94 ± 1.12 *µ*l/min. The comparable flow rates between the two capillary tubes demonstrated the self-consistency in the multimodal measurement, which also agreed with the pump value.

3.2. In vivo results {#sec2-2}
--------------------

To test the feasibility of measuring MRO~2~, the microvasculature in mouse ears was used as an analogue of retinal vessels because both objects are optically thin.

[Figure 3](#g003){ref-type="fig"} Fig. 3Multimodal anatomic imaging of a mouse ear. (a) LSOR-PAM projection image of an artery-vein pair; (b) LSOR-PAM B-Scan image acquired at the 570-nm optical wavelength at the location marked by the dashed line in panel a; (c) OCT B-Scan image acquired at the same location. A: Artery; V: Vein; Ep, epidermis; De, dermis; Ca, cartilaginous backbone; Bar: 100 *µ*m. shows the *in vivo* anatomic images. The mean-amplitude-projection image of two parallel vessels (an artery-vein pair) is shown in [Fig. 3a](#g003){ref-type="fig"}. The quantification of sO~2~ and blood flow in these two vessels was performed in B-scan images at the location highlighted by the dashed line. [Figure 3b](#g003){ref-type="fig"} shows the PAM B-scan image acquired at 570 nm after being averaged over 256 consecutive B-scans, where the two vessels are clearly dominating. [Figure 3c](#g003){ref-type="fig"} shows the corresponding OCT B-scan image at the same location, where skin anatomy and the cartilage layer are visualized but not the blood vessels. However, the shadows created by the vessel pair can be observed.

[Figure 4](#g004){ref-type="fig"} Fig. 4Multimodal functional imaging. (a) Imaged sO~2~ using LSOR-PAM; (b) Imaged blood flow velocity using SD-OCT. Bar: 100 *µ*m. shows the functional imaging results. The sO~2~ values were calculated based on the B-scan images acquired at the four optical wavelengths after a 3 × 3 spatial averaging in each B-scan image and only the peak PA amplitudes of the two vessels were used. The measured sO~2~ distinguished the artery (sO~2a~ = 68.9%) and vein (sO~2v~ = 38.3%) in the vessel pair ([Fig. 4a](#g004){ref-type="fig"}). The vessel diameters were measured to be *d*~a~ = 42.69 ± 0.09 *µ*m and *d*~v~ = 61.13 ± 0.25 *µ*m using the method as we used in the flow phantom.

[Figure 4b](#g004){ref-type="fig"} shows the Doppler OCT results. The angle between the surface of the mouse ear and the horizontal plane was 3.8°; hence, the Doppler angle was *θ* = 86.2°, which is comparable with the reported Doppler angle in human eyes \[[@r8]\]. The mean velocities were ${\overline{v}}_{a}$ = −15.58 ± 0.43 mm/s and ${\overline{v}}_{v}$ = 8.11 ± 0.48 mm/s, as shown in [Fig. 4b](#g004){ref-type="fig"}.

We compared the blood flow rate in this vessel pair. Using the measured blood flow velocities and diameters, we have *F~a~* = 1.34 ± 0.04 µl/min and *F~v~* = 1.43 ± 0.10 µl/min, which are comparable and, thus, shows that the measurements are self-consistent.

Finally, based on the $\overline{\text{HbT}}$ value of 344 g/L, the MRO~2~ was 242.77 ± 30.50 ng/min, assuming that the vessel pair supports the same tissue volume. We want to point out here that MRO~2~ depends on the subject and the anatomic sites because sO~2~ and blood flow vary significantly between subjects and anatomic locations.

We further converted the measured MRO~2~ into a more commonly used unit of liter/min. The ideal gas law \[[@r19]\] calculates the volume of oxygen (gas) from its weight by
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where *n~g~* is the number of moles of gas, *R* is the molar gas constant 8.3145 J·mole^−1^·K^−1^, *T* is the blood temperature (311.15 K), and *P* is the standard atmosphere pressure (101,325 Pa). Based on the molar mass of oxygen (32 g/mol), the MRO~2~ is 193.70 ± 24.33 nl/min.

In the current study, the blood flow velocity was measured by SD-OCT. Although transverse blood flow velocity can be measured by both amplitude-modulated continuous-wave and pulsed illuminating PAM \[[@r20],[@r21]\], these methods require extra visible light exposure, which is not preferred in ophthalmic imaging. PAM also has the potential to measure $\overline{\text{HbT}}$ if one of the isosbestic optical wavelengths in the molar extinction coefficient spectra of the oxy- and deoxy-hemiglobin \[[@r15]\] is used and the correlation between the hemoglobin concentration and the measured PA amplitude is calibrated. However, such a capability has not been reported yet and, oftentimes, the calibration is not trivial in *in vivo* studies as the actual measured PA amplitude can be affected by local optical fluence and is strongly sample dependent. Taking blood sample is routine in many of the existing clinical diagnosis and, more important, it will be much more precise.

We need to address a few issues in the future. First, a higher SNR in the LSOR-PAM needs to be achieved. Since an unfocused rather than a strongly focused ultrasonic transducer is used to coordinate with the optical scanning for a much higher imaging speed, the SNR becomes worse and signal averaging is required to minimize the errors in sO~2~ calculation. A weakly spherical focused ultrasonic transducer can potentially be employed. Second, the Doppler angle was introduced by tilting the sample in this study, which was hard to control in patient. A dual-beam OCT can potentially be used to avoid tilting the samples and still measures the absolute blood flow velocity \[[@r22]\].

No compensation for the wavelength-dependent fluence attenuation was conducted in this study. Although missing or poor optical fluence compensation leads to a noticeable measurement inaccuracy in deep tissue \[[@r23],[@r24]\], it is unlikely to affect the application in ophthalmology \[[@r25]\] since the medium between cornea and retinal vessel (vitreous humor) is often considered transparent, inducing minimal attenuation of light within the visible and NIR spectral range.

4. Conclusion {#sec1-4}
=============

In conclusion, we demonstrated the feasibility of measuring MRO~2~ using a combined LSOR-PAM and SD-OCT multimodal system. The multimodal imaging system was first tested in a flow phantom. Then i*n vivo* measurement of MRO~2~ was achieved in microvessels and the measured parameters by different modalities were self-consistent. This work lays the foundation for the next-stage retinal MRO~2~ imaging, which has great potential in both fundamental study and clinical early diagnosis of several blinding diseases.
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